Biogen shares jump 4.7% premarket on hopes for its Alzheimer’s treatment lecanemab
admin Biogen Inc. shares BIIB, -0.43% rose 4.7% in premarket trade Monday, after MorphoSys and partner…
Read Morelecanemab
Biogen and Eisai make plans to take another Alzheimer’s drug to the FDA
Biogen Inc. BIIB, -1.93% and Eisai Co. Ltd. 4523, +3.57% are getting closer to a…
Read More